Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
"SSU72L4" (also referred to as "SSU72 RNA polymerase II CTD phosphatase homolog pseudogene 4") is not an active protein or enzyme but a pseudogene, meaning it does not encode a functional protein product. The canonical, functional SSU72 is a phosphatase involved in dephosphorylating serine-5 and serine-7 of the RNA polymerase II C-terminal domain, critically regulating the transcription cycle in eukaryotes and participating in processes such as transcription initiation, elongation, termination, and phosphate homeostasis[1][2][3][5]. However, "SSU72L4" specifically refers to a pseudogene homolog of SSU72 and not to the active, canonical SSU72 phosphatase protein. Notes: - The functional SSU72 protein plays essential, well-studied roles in transcriptional regulation and cell viability, but the "SSU72L4" pseudogene does not perform these functions[2][5]. - There are no known drugs, biological functions, or disease roles associated with SSU72L4, as it is a non-coding pseudogene. - The presence of multiple aliases and description strings for "SSU72L4" represents redundant or alternate ways of referring to this nonfunctional gene locus. - This entry may result from confusion with the active SSU72 phosphatase, but "SSU72L4" itself is not a recognized pharmacological or research target. Summary: "SSU72L4" is a non-functional pseudogene, not a therapeutic target, enzyme, or receptor. All function and research relevance pertain to the active SSU72 enzyme, not this pseudogene homolog[2][5].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on SSU72 RNA polymerase II CTD phosphatase homolog pseudogene 4 (SSU72L4).